NCT00160563View on ClinicalTrials.gov

Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

PHASE3TerminatedINTERVENTIONAL

Enrollment

207

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Asthma

Interventions

DRUG

LEVOCETIRIZINE

5mg/mL oral drops, 0.125 mg/kg body weight, bid for 18 months

OTHER

Placebo

Oral drops, bid for 18 months

Trial Locations (51)

Unknown

North Adelaide

Parkville (North Melbourne)

Brussels

Brno

Hradec Králové

Olomouc

Ostrava

Plezen-Lochotin

Prague

Martigues

Saint-Etienne

Tarbes

Toulouse

Bayreuth

Berlin

Bielefeld

Bochum

Cologne

Erlangen

München

Wesel

Ancona

Bari

Bologna

Messina

Milan

Napoli

Pavia

Roma

Bialystock

Gdansk

Karpacz

Lodz

Lublin

Rabka-Zdrój

Warsaw

Wroclaw

Bellville

Clarement

Durban

Mowbray

Pietermaritzburg

Sydenham

West Honeydew

Westville

Wynberg

Barcelona

Espluques de Llobreqat

Dorchester

Enfield

Southampton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY